Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

NCT07226466 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07226466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from solid tumors, brain tumor, brain tumor adult, brain tumor, primary